Delegates also disagreed on the appropriate placement and language of a target related to the research and development of, and access to, vaccines and medicines (3.b), focusing especially on language relating to the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) regarding flexibilities to protect public health.